{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:00:08Z","timestamp":1772769608078,"version":"3.50.1"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,2,1]]},"DOI":"10.2169\/internalmedicine.5312-25","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T22:07:43Z","timestamp":1752098863000},"page":"411-419","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine Monotherapy"],"prefix":"10.2169","volume":"65","author":[{"given":"Takafumi","family":"Furumoto","sequence":"first","affiliation":[{"name":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Department of Hematology, Sasebo City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eo","family":"Toriyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Hata","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nagasaki Harbor Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Katsuoka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Department of Hematology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Department of Hematology, NHO Nagasaki Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamitsu","family":"Ichinose","sequence":"additional","affiliation":[{"name":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Department of Hematology, Sasebo City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Department of Hematology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machiko","family":"Fujioka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Department of Hematology, Sasebo City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Sakaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, NHO Nagasaki Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Chiwata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japan Community Health Care Organization Isahaya General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rena","family":"Kamijo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Sasebo City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Department of Hematology, NHO Nagasaki Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kitanosono","sequence":"additional","affiliation":[{"name":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Department of Hematology, Nagasaki Prefecture Shimabara Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japan Community Health Care Organization Isahaya General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeharu","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Horai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Makiyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Sasebo City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiro","family":"Itonaga","sequence":"additional","affiliation":[{"name":"Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Sawayama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Takasaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Saint Francis Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Imanishi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nagasaki Prefecture Gotochuoh Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Imaizumi","sequence":"additional","affiliation":[{"name":"Department of Hematology, NHO Nagasaki Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, NHO Nagasaki National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Tsushima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagasaki Harbor Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Hematology, NHO Nagasaki Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiyoshi","family":"Moriuchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Sasebo City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Japan"},{"name":"Department of Hematology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Oster HS, Van de Loosdrecht AA, Mittelman M. Diagnosis of myelodysplastic syndromes: the classic and the novel. Haematologica 110: 300-311, 2025.","DOI":"10.3324\/haematol.2023.284937"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89: 2079-2088, 1997.","DOI":"10.1182\/blood.V89.6.2079"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Greenberg PL, Tuechler H, Schanz J, et al. Revised International Prognostic Scoring System for myelodysplastic syndromes. Blood 120: 2454-2465, 2012.","DOI":"10.1182\/blood-2012-03-420489"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Platzbecker U. Treatment of MDS. Blood 133: 1096-1107, 2019.","DOI":"10.1182\/blood-2018-10-844696"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Witte TD, Bowen D, Robin M, et al. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel. Blood 129: 1753-1762, 2017.","DOI":"10.1182\/blood-2016-06-724500"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Guillermo GM. Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol 98: 1307-1325, 2023.","DOI":"10.1002\/ajh.26984"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mina A, Komrokji R. How I treat higher-risk MDS. Blood 145: 2002-2011, 2025.","DOI":"10.1182\/blood.2024025271"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kr\u00f6ger N. Treatment of high-risk myelodysplastic syndromes. Haematologica 110: 339-349, 2025.","DOI":"10.3324\/haematol.2023.284946"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Usuki K, Ohtake S, Honda S, et al. Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11). Int J Hematol 119: 130-145, 2024.","DOI":"10.1007\/s12185-023-03686-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kota V, Ogbonnaya E, Farrelly B, et al. Clinical impact of transformation to acute myeloid leukemia in patients with higher-risk myelodysplastic Syndromes. Future Oncol 36: 4017-4029, 2022.","DOI":"10.2217\/fon-2022-0334"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Boddu P, Kantarjian HM, Garcia-Manero G, et al. Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis. Blood Adv 1: 1312-1323, 2017.","DOI":"10.1182\/bloodadvances.2017008227"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Talati C, Goldberg AD, Przespolewski A, et al. Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy. Leuk Res 93: 106367, 2020.","DOI":"10.1016\/j.leukres.2020.106367"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Richardson DR, Green SD, Foster MC, Zeidner JF. Secondary AML emerging after therapy with hypomethylating agents: outcomes, prognostic factors, and treatment options. Curr Hematol Malig Rep 16: 97-111, 2021.","DOI":"10.1007\/s11899-021-00608-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. DiNardo CD, Jonas BA, Pullarkat V, et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med 383: 617-629, 2020.","DOI":"10.1056\/NEJMoa2012971"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127: 2391-2405, 2016.","DOI":"10.1182\/blood-2016-03-643544"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. D\u00f6hner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129: 424-447, 2017.","DOI":"10.1182\/blood-2016-08-733196"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kanda Y. Investigation of the freely available easy-to-use software &apos;EZR&apos; for medical statistics. Bone Marrow Transplant 48: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Todisco E, Papayannidis C, Fracchiolla N, et al.; the AVALON Cooperative Group. AVALON: the Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed\/refractory patients with acute myeloid leukemia. Cancer 129: 992-1004, 2023.","DOI":"10.1002\/cncr.34608"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Konopleva M, Pollyea DA, Potluri J, et al. Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia. Cancer Discov 6: 1106-1117, 2016.","DOI":"10.1158\/2159-8290.CD-16-0313"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bogenberger JM, Kornblau SM, Pierceall WE, et al. BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies. Leukemia 29: 1657-1665, 2014.","DOI":"10.1038\/leu.2014.44"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/3\/65_5312-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:46:44Z","timestamp":1770436004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/3\/65_5312-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5312-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"article-number":"5312-25"}}